External validation of a sunitinib prognostic nomogram in patients (pts) with metastatic renal cell carcinoma (mRCC).
2017
e15070 Background: A nomogram was previously developed from pretreatment clinical features to predict the probability of achieving 12-month progression-free survival (PFS) with sunitinib in treatme...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI